Electronic Pill Bottle Monitoring to Promote Medication Adherence for People With Multiple Sclerosis

NCT04130256 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 85

Last updated 2021-07-30

No results posted yet for this study

Summary

People with multiple sclerosis (MS) have variable adherence to MS medications, making the full efficacy of disease modifying therapies unrealized and the assessment of true treatment failures challenging. Whereas some patients forget to take medications due to active lifestyles, others may have cognitive impairments that prevent them from organizing and planning their regular dosing schedules. An electronic pill cap ("Pillsy") has been developed to record pill taking, timing, and set reminders through a mobile app. Data on adherence can be captured and analyzed remotely for health care provider review.

Conditions

Interventions

DEVICE

Electronic Pill Bottle

Electronic bottles that can beep and blink to send medication use reminders, record medication use data, and upload medication use data to a secure server.

Sponsors & Collaborators

  • National Multiple Sclerosis Society

    collaborator OTHER
  • Pillsy, Inc.

    collaborator UNKNOWN
  • Massachusetts General Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-15
Primary Completion
2021-01-26
Completion
2021-01-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04130256 on ClinicalTrials.gov